It would be like a team of doctors arguing over whether a program of treating a patient afflictedwith cancer with nothing stronger than aspirin would be effective if permitted to continue for six-months or a year.
It would be like a team of doctors arguing over whether a program of treating a patient afflictedwith cancer with nothing stronger than aspirin would be effective if permitted to continue for a six-months or a year.
It therefore behooves those companies afflictedwith leaks to start with a very simple question--what should we be doing to make leaks less attractive as a methodology to solve internal concerns or disagreements?